There are differences in IgE reactivity to rBet v 1 and rBet v 2 among allergic patients from the six countries studied. The complexity of the reactivity profile tends to be greater in individuals from the central/southern parts of Europe compared to Sweden and Finland. There is a good agreement between in vitro diagnosis with Pharmacia CAP System and Skin prick testing when using the same reagents, rBet v 1 and rBet v 2.
展开▼